FdaApplication

NDA 022499

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTRIS PHARMA INC
application_typeNDA
approval_date2009-12-03

Products (1)

ProductActive ingredientStrengthDosage form
CLONIDINECLONIDINEEQ 0.09MG BASE/MLSUSPENSION, EXTENDED RELEASE;ORAL

1 product